Psychoactive substances with chemical structures or pharmacological profiles that are
similar to traditional drugs of abuse continue to emerge on the recreational drug market …

ADB-FUBINACA and AMB-FUBINACA are two synthetic indazole-derived cannabinoid
receptor agonists, up to 140-and 85-fold more potent, respectively, than trans-∆ 9 …

A 28-year-old man is evaluated by emergency medical technicians after a bystander calls
911 for concern about altered mental status. On arrival, the man is slow to respond to …

Objective We describe a multicenter descriptive case series of six patients admitted with
synthetic cannabinoid (SC) intoxication displaying similar symptoms and sequelae, all …

Purpose The use of novel synthetic cannabinoids as intoxicants continues in spite of
associated health risks. These compounds are typically smoked or vaporized, but many …

Synthetic drugs of abuse contain various psychoactive substances. These substances have
recently emerged as novel drugs of abuse in public; thus, they are known as novel …

Background. Synthetic cannabinoid-related acute kidney injury represents an increasingly
important public health issue due to the diagnostic challenges given by low clinical …

Rhabdomyolysis (RM), a fortunately rare disease of the striated muscle cells, is a
complication of non-traumatic (congenital (glycogen storage disease, discrete mitochondrial …

Major depressive disorder is a mental disorder affecting millions of people worldwide. A
considerable proportion of patients demonstrate a lack of response to conventional …

Rhabdomyolysis has been reported in patients who abuse synthetic cannabinoids.
However, no studies have yet assessed whether these cases reflect the direct cytotoxicity of …